Biosante Pharmaceuticals shares owned by Wakefield Asset Management L
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Wakefield Asset Management L
from 13F filings
Historical chart of Wakefield Asset Management L investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Wakefield Asset Management L consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Wakefield Asset Management L
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3M | 14k | 91.60 |
| 2025-06-30 | $1.1M | 17k | 65.25 |
| 2025-03-31 | $1.2M | 17k | 66.95 |
| 2024-09-30 | $824k | 14k | 59.66 |
| 2024-06-30 | $891k | 14k | 63.68 |
| 2024-03-31 | $979k | 14k | 69.13 |
| 2023-09-30 | $717k | 12k | 58.06 |
| 2023-06-30 | $941k | 18k | 53.83 |
More positions owned by Wakefield Asset Management L
View all positions for Wakefield Asset Management L